Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Definium Therapeutics Inc. Common Shares (DFTX) vs State Street Corporation Common Stock (STT) Price & Performance

Definium Therapeutics Inc. Common SharesTrade
State Street Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Definium Therapeutics Inc. Common Shares vs State Street Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.97 (market cap $4.59B), while State Street Corporation Common Stock trades at $174.55 (market cap $48.10B). The key difference: State Street Corporation Common Stock is far larger — about 10.5× Definium Therapeutics Inc. Common Shares's market cap, and State Street Corporation Common Stock pays a 2.1% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and State Street Corporation Common Stock for 0 Days on average.

DFTXSTT
Market Cap
$4.59B$48.10B
Volume
2,103,9372,033,865
Sector
HealthFinancials
52-Week High
$48.45$194.26
52-Week Low
$10.68$111.00
Typical Hold Time
0 Days0 Days
Enterprise Value
$3.55B$74.64B
Dividend Yield
—2.1%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DFTX
100% Buy0% Sell
Avg holding period · 0 Days
STT
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Definium Therapeutics Inc. Common Shares

Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.

Read more on DFTX →

About State Street Corporation Common Stock

State Street provides investment servicing, custody, and asset management services to institutional investors. Its asset management business includes the SPDR ETF range.

Read more on STT →